News

Gordon Brothers, the global advisory, restructuring and investment firm, will sell private treaty machinery and equipment from four plants in the Canary Islands formerly leased by the firm to José Sánchez Peñate, a Spanish food products manufacturer and distributor.

Octaura, the electronic trading platform for syndicated loans, executed its initial syndicated loan trades. Upon the success of the initial syndicated loan trades, the company will move forward with releasing its beta version for loan trading sessions prior to official...

The Federal Reserve announced that it will raise the target range for the federal funds rate to between 4.5% and 4.75%, marking a quarter point increase. The move was less drastic than its seven rate increases in 2022, with all...

Great Lakes Business Credit announced a rebranding, with the new name of Bridge Business Credit. Under its new name, the Bridge Business Credit team of experienced financial professionals will serve operating companies located throughout the Central and Eastern U.S. time...

Aruze Gaming, a developer of gambling entertainment solutions for the global casino market, filed a voluntary petition under Chapter 11 of the Bankruptcy Code in the United States Bankruptcy Court for the State of Nevada.

Atalaya Capital Management completed fundraising for its eighth Special Opportunities Fund (ASOF VIII). The oversubscribed fund closed with $1.8 billion of commitments given significant support from both new and existing partnerships with investors.

Rosenthal & Rosenthal completed a pair of factoring transactions, including a $1.75 million domestic and international non-recourse factoring deal for a leading manufacturer of antimicrobial products and a $1.5 million non-recourse factoring deal for a wholesale premium seafood distributor.

J D Factors provided $3.15 million in recent factoring facilities to 12 clients.

KBRA assigned preliminary ratings to five classes of debt issued by Monroe Capital ABS Funding II (MCAF II), a securitization backed by a portfolio of recurring revenue and middle market corporate loans.

Acerus Pharmaceuticals and its subsidiaries, Acerus Biopharma, Acerus Labs and Acerus Pharmaceuticals USA, have received an order for creditor protection from the Ontario Superior Court of Justice under the Companies’ Creditors Arrangement Act (the CCAA).